Hypoxia enables B19 erythrovirus to yield abundant infectious progeny in a pluripotent erythroid cell line

Journal of Virological Methods

Volumn 121, Issue 2, 2004, Pages 145-153

  Caillet Fauquet, P ^a   Draps, M L ^a   Giambattista, M Di ^b   Launoit, Y De ^a,c   Laub, Ruth ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Central Department for Fractionation   (Belgium)

^c UNIV LILLE   (France)

Author keywords

B19 infectivity assay; Hypoxia; Neutralization; Plasma

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS DNA;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL LINE; DNA DETERMINATION; ERYTHEMA INFECTIOSUM; ERYTHROID CELL; HUMAN; HUMAN CELL; HYPOXIA; MICROBIOLOGICAL EXAMINATION; NONHUMAN; OXYGEN TENSION; PARVOVIRUS; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGENY; SENSITIVITY AND SPECIFICITY; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS TRANSCRIPTION; WORLD HEALTH ORGANIZATION;

CAPSID PROTEINS; CELL HYPOXIA; CELL LINE; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; HUMANS; IMMUNOGLOBULIN G; PARVOVIRUS B19, HUMAN; TIME FACTORS; VIRUS CULTIVATION;

ERYTHROVIRUS;

EID: 4644323295     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2004.06.010     Document Type: Article

References (50)

1. D.M. Adelman, M. Gertsenstein, A. Nagy, M.C. Simon, and E. Maltepe Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses Genes Dev. 14 24 2000 3191 3203
2. J.T. Aubin, C. Defer, M. Vidaud, M. Maniez Montreuil, and B. Flan Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation Vox Sang. 78 1 2000 7 12
3. F. Blaschke, P. Stawowy, S. Goetze, O. Hintz, M. Grafe, U. Kintscher, E. Fleck, and K. Graf Hypoxia activates beta (1)-integrin via ERK 1/2 and p38 MAP kinase in human vascular smooth muscle cells Biochem. Biophys. Res. Commun. 296 4 2002 890 896
4. J. Blumel, I. Schmidt, W. Effenberger, H. Seitz, H. Willkommen, H.H. Brackmann, J. Lower, and A.M. Eis-Hubinger Parvovirus B19 transmission by heat-treated clotting factor concentrates Transfusion 42 11 2002 1473 1481
5. J. Blumel, I. Schmidt, H. Willkommen, and J. Lower Inactivation of parvovirus B19 during pasteurization of human serum albumin Transfusion 42 8 2002 1011 1018
6. K.E. Brown, S.M. Anderson, and N.S. Young Erythrocyte P antigen: cellular receptor for B19 parvovirus Science 262 5130 1993 114 117
7. K.E. Brown, N.S. Young, B.M. Alving, and L.H. Barbosa Parvovirus B19: implications for transfusion medicine. Summary of a workshop Transfusion 41 1 2001 130 135
8. J. Brunstein, M. Soderlund-Venermo, and K. Hedman Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19 Virology 274 2 2000 284 291
9. Caillet-Fauquet, P., Di Giambattista, M., Draps, M.-L., de Launoit, Y., Laub, R. An assay for parvovirus B19 neutralizing antibodies based on human hepatocarcinoma cell lines, in press.
10. P. Caillet-Fauquet, M. Di Giambattista, M.-L. Draps, F. Sandras, T. Branckaert, Y. de Launoit, and R. Laub Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19 J. Virol. Methods 118 2 2004 131 139
11. I. Caniggia, J. Winter, S.J. Lye, and M. Post Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia Placenta 21 Suppl A 2000 S25 30
12. G.H. Danet, Y. Pan, J.L. Luongo, D.A. Bonnet, and M.C. Simon Expansion of human SCID-repopulating cells under hypoxic conditions J. Clin. Invest. 112 1 2003 126 135
13. D.A. Davis, A.S. Rinderknecht, J.P. Zoeteweij, Y. Aoki, E.L. Read-Connole, G. Tosato, A. Blauvelt, and R. Yarchoan Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus Blood 97 10 2001 3244 3250
14. P. Ebbesen, E.O. Pettersen, J. Denekamp, B. Littbrand, J. Keski-Oja, A. Schousboe, U. Sonnewald, O. Amellem, and V. Zachar Hypoxia, normoxia and hyperoxia terminology for medical in vitro cell biology Acta Oncol. 39 2 2000 247 248
15. P. Ebbesen, and V. Zachar Oxygen tension and virus replication Acta Virol. 42 6 1998 417 421
16. M. Ferguson, D. Walker, and B. Cohen Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG Biologicals 25 3 1997 283 288
17. T.H. Finkel, T.J. Torok, P.J. Ferguson, E.L. Durigon, S.R. Zaki, D.Y. Leung, R.J. Harbeck, E.W. Gelfand, F.T. Saulsbury, and J.R. Hollister Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343 8908 1994 1255 1258
18. G. Gallinella, E. Manaresi, E. Zuffi, S. Venturoli, L. Bonsi, G.P. Bagnara, M. Musiani, and M. Zerbini Different patterns of restriction to B19 parvovirus replication in human blast cell lines Virology 278 2 2000 361 367
19. M.J. Grimshaw, and R.M. Mason Modulation of bovine articular chondrocyte gene expression in vitro by oxygen tension Osteoarthritis Cartilage 9 4 2001 357 364
20. U.F. Koenigbauer, T. Eastlund, and J.W. Day Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma Transfusion 40 10 2000 1203 1206
21. R. Laub, and P. Strengers Parvoviruses and blood products Pathol. Biol. (Paris) 50 5 2002 339 348
22. J.S. Lewis, J.A. Lee, J.C. Underwood, A.L. Harris, and C.E. Lewis Macrophage responses to hypoxia: relevance to disease mechanisms J. Leukoc. Biol. 66 6 1999 889 900
23. E. Minet, G. Michel, D. Mottet, M. Raes, and C. Michiels Transduction pathways involved in Hypoxia Inducible Factor-1 phosphorylation and activation Free Radic. Biol. Med. 31 7 2001 847 855
24. E. Miyagawa, T. Yoshida, H. Takahashi, K. Yamaguchi, T. Nagano, Y. Kiriyama, K. Okochi, and H. Sato Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity J. Virol. Methods 83 1-2 1999 45 54
25. P.P. Mortimer, R.K. Humphries, J.G. Moore, R.H. Purcell, and N.S. Young A human parvovirus-like virus inhibits haematopoietic colony formation in vitro Nature 302 5907 1983 426 429
26. S.S. Mostafa, W.M. Miller, and E.T. Papoutsakis Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes Br. J. Haematol. 111 3 2000 879 889
27. M. Nakazawa, M.T. Mitjavila, N. Debili, N. Casadevall, P. Mayeux, P. Rouyer-Fessard, A. Dubart, P.H. Romeo, Y. Beuzard, and K. Kishi KU812: a pluripotent human cell line with spontaneous erythroid terminal maturation Blood 73 7 1989 2003 2013
28. K. Ozawa, G. Kurtzman, and N. Young Replication of the B19 parvovirus in human bone marrow cell cultures Science 233 4766 1986 883 886
29. Papayannopoulou, T., Ablowitz, 1995. Biology of erythropoiesis, erythroid differentiation and maturation. In: Hoffman, R., Bentz, E.J., Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E. (Eds.), Hematology Basic Principles and Practice. Churchill Livingtone, New York, pp. 242-254.
30. Pillet, S., Le Guyader, N., Hofer, T., NguyenKhac, F., Koken, M., Aubin, J.-T., Fichelson, S., Gassmann, M., Morinet, F. Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells. Virology, in press.
31. V.R. Polonis, G.R. Anderson, M.T. Vahey, P.J. Morrow, D. Stoler, and R.R. Redfield Anoxia induces human immunodeficiency virus expression in infected T cell lines J. Biol. Chem. 266 18 1991 11421 11424
32. D.E. Richard, E. Berra, E. Gothie, D. Roux, and J. Pouyssegur p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1 J. Biol. Chem. 274 46 1999 32631 32637
33. H.J. Riedinger, M. van Betteraey, and H. Probst Hypoxia blocks in vivo initiation of simian virus 40 replication at a stage preceding origin unwinding J. Virol. 73 3 1999 2243 2252
34. T. Saito, Y. Munakata, Y. Fu, H. Fujii, T. Kodera, E. Miyagawa, K. Ishii, and T. Sasaki Evaluation of anti-parvovirus B19 activity in sera by assay using quantitative polymerase chain reaction J. Virol. Methods 107 1 2003 81 87
35. J. Saldanha, W. Gerlich, N. Lelie, P. Dawson, K. Heermann, and A. Heath An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques Vox. Sang. 80 1 2001 63 71
36. S. Schorling, G. Schalasta, G. Enders, and M. Zauke Quantification of Parvovirus B19 DNA using COBAS AmpliPrep automated sample preparation and lightcycler real-time PCR J. Mol. Diagn. 6 1 2004 37 41
37. G.L. Semenza HIF-1 and mechanisms of hypoxia sensing Curr. Opin. Cell Biol. 13 2 2001 167 171
38. R.O. Shade, M.C. Blundell, S.F. Cotmore, P. Tattersall, and C.R. Astell Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis J. Virol. 58 3 1986 921 936
39. S. Shimomura, N. Komatsu, N. Frickhofen, S. Anderson, S. Kajigaya, and N.S. Young First continuous propagation of B19 parvovirus in a cell line Blood 79 1 1992 18 24
40. K. Smith-Whitley, H. Zhao, R.L. Hodinka, J. Kwiatkowski, R. Cecil, T. Cecil, A. Cnaan, and K. Ohene-Frempong Epidemiology of human parvovirus B19 in children with sickle cell disease Blood 103 2 2004 422 427
41. M. Soderlund-Venermo, K. Hokynar, J. Nieminen, H. Rautakorpi, and K. Hedman Persistence of human parvovirus B19 in human tissues Pathol. Biol. (Paris) 50 5 2002 307 316
42. H. Sugawara, R. Motokawa, H. Abe, M. Yamaguchi, Y. Yamada-Ohnishi, J. Hirayama, H. Sakata, S. Sato, N. Kamo, K. Ikebuchi, and H. Ikeda Inactivation of parvovirus B19 in coagulation factor concentrates by UVC radiation: assessment by an in vitro infectivity assay using CFU-E derived from peripheral blood CD34+ cells Transfusion 41 4 2001 456 461
43. T. Takahashi, K. Ozawa, K. Takahashi, S. Asano, and F. Takaku Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation Blood 75 3 1990 603 610
44. I. Thomas, M. Di Giambattista, C. Gerard, E. Mathys, V. Hougardy, B. Latour, T. Branckaert, and R. Laub Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins Vox. Sang. 84 4 2003 300 307
45. T. Van Lieshout, J. Stanisz, V. Espiritu, M. Richardson, and G. Singh A hypoxic response induced in MatLyLu cells by cobalt chloride results in an enhanced angiogenic response by the chick chorioallantoic membrane Int. J. Oncol. 23 3 2003 745 750
46. 2 tension Proc. Natl. Acad. Sci. USA 92 12 1995 5510 5514
47. K.A. Weigel-Kelley, M.C. Yoder, and A. Srivastava Alpha 5 beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry Blood 102 12 2003 3927 3933
48. N. Yaegashi, H. Shiraishi, T. Takeshita, M. Nakamura, A. Yajima, and K. Sugamura Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver J. Virol. 63 6 1989 2422 2426
49. N.S. Young, and K.E. Brown Parvovirus B19 N. Engl. J. Med. 350 6 2004 586 597
50. M. Yunoki, M. Tsujikawa, T. Urayama, Y. Sasaki, M. Morita, H. Tanaka, S. Hattori, K. Takechi, and K. Ikuta Heat sensitivity of human parvovirus B19 Vox. Sang. 84 3 2003 164 169